申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US04557871A1
公开(公告)日:1985-12-10
Novel styrene derivatives of the general formula ##STR1## wherein X is hydrogen or halogen, X.sup.1 is halogen, R is hydrogen or methyl, Y is hydroxymethyl, carboxyl, --COOR.sup.1 or --COR.sup.2 wherein R.sup.1 is prenyl, geranyl, farnesyl, cyclohexyl, phthalidyl, straight or branched chain alkyl having 1 to 6 carbon atoms, or said alkyl substituted with hydroxy, methoxy, pyridyl or alkanoyloxy having 2 to 16 carbon atoms, and R.sup.2 is amino, hydroxyamino mono-(or di-)alkylamino in which the alkyl moiety contains 1 or 2 carbon atoms, ethoxycarbonylmethylamino, carboxymethylamino, thiazolylamino, cyclohexylamino, pyridylamino, morpholino, N-methylpiperazino, phenylamino, phenylamino substituted with one or two of halogen, hydroxy, methyl, methoxy, trifluoromethyl or carboxyl at the phenyl ring, and the pharmaceutically acceptable salts thereof when Y is carboxyl are disclosed. These compounds exhibit high and long-lasting anti-inflammatory, analgesic and anti-pyretic activity.
本发明涉及一种新型
苯乙烯衍
生物,其一般式为:##STR1## 其中X为氢或卤素,X.sup.1为卤素,R为氢或甲基,Y为羟甲基,羧基,--COOR.sup.1或--COR.sup.2,其中R.sup.1为异
戊烯基,蒿莱基,法尼基,环己基,
邻苯二甲酰基,1-6碳原子的直链或支链烷基,或带有2-16碳原子的羟基,甲氧基,
吡啶基或脂肪酰氧基的取代的烷基,而R.sup.2为
氨基,
羟胺单(或二)-烷基
氨基,其中烷基部分含有1或2个碳原子,乙氧羰基甲基
氨基,羧甲基
氨基,
噻唑基
氨基,环己基
氨基,
吡啶基
氨基,吗啉基,
N-甲基哌嗪基,苯基
氨基,苯基
氨基在苯环上取代有一个或两个卤素,羟基,甲基,甲氧基,三
氟甲基或羧基,当Y为羧基时,其药物可接受的盐也被揭示。这些化合物表现出高效和持久的抗炎,镇痛和退烧活性。